GPX3 and Barrett esophagus: In EAC cases, they observed promoter hypermethylation of GPX3, GPX7, GSTM2, and GSTM3; hypermethylation was likewise present in BE and Barrett’s dysplasia (BD), suggesting an early event in adenocarcinoma development, as measured by quantitative bisulfite pyrosequencing [126].